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Abstract
Aims/hypothesis Structured exercise is considered a corner-
stone in type 2 diabetes treatment. However, adherence to
combined resistance and endurance type exercise or medical
fitness intervention programmes is generally poor. Group-
based brisk walking may represent an attractive alternative,
but its long-term efficacy as compared with an individualised
approach such as medical fitness intervention programmes is
unknown. We compared the clinical benefits of a 12-month
exercise intervention programme consisting of either brisk
walking or a medical fitness programme in type 2 diabetes
patients.
Methods We randomised 92 type 2 diabetes patients (60±
9 years old) to either three times a week of 60 min brisk
walking (n=49) or medical fitness programme (n=43).
Primary outcome was the difference in changes in HbA1c
values at 12 months. Secondary outcomes were differences in
changes in blood pressure, plasma lipid concentrations, insulin
sensitivity, body composition, physical fitness, programme
adherence rate and health-related quality of life.
Results After 12 months, 18 brisk walking and 19 medical
fitness participants were still actively participating. In both
programmes, 50 and 25% of the dropout was attributed to
overuse injuries and lack of motivation, respectively. Inten-
tion-to-treat analyses showed no important differences
between brisk walking and medical fitness programme in
primary or secondary outcome variables.
Conclusions/interpretation The prescription of group-based
brisk walking represents an equally effective intervention to
modulate glycaemic control and cardiovascular risk profile in
type 2 diabetes patients when compared with more individ-
ualised medical fitness programmes. Future exercise inter-
vention programmes should anticipate the high attrition rate
due to overuse injuries and motivation problems.
Keywords Blood pressure . Exercise . Hyperglycaemia .
Lipid metabolism . Physical fitness . Randomised controlled
clinical trial . Type 2 diabetes mellitus
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2peak peak oxygen uptake capacity
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Introduction
Regular exercise has been identified along with diet and
medication as one of the three components of good diabetes
therapy [1]. Structured exercise intervention programmes
have been reported to be as effective as pharmaceutical
strategies in improving glycaemic control [2–5] and/or
cardiovascular risk profile [6, 7] in type 2 diabetes patients.
Despite the growing body of scientific evidence on the
health benefits of exercise intervention, most meta-analyses
report a lack of studies that have tried to assess the long-term
efficacy of exercise intervention in type 2 diabetes patients
[3–5, 7–9]. In general, exercise intervention studies imple-
ment endurance and resistance type exercise, supervised by a
physical therapist [10–17]. The long-term adherence to these
(so-called) medical fitness programmes has been shown to
range between 10 and 80% [11, 18–20]. Financial costs per
patient are considerable in such programmes. Brisk walking
exercise has been proposed as a less expensive alternative,
with a good clinical outcome when patients are frequently
counselled by motivated, supportive physicians [6, 21, 22].
However, brisk walking programmes mainly consist of
endurance type exercise activities. As combined endurance
and resistance type exercise training has been reported to be
of greater clinical benefit [3, 23], it is conceivable that the
long-term efficacy of a medical fitness programme is greater
than that of a brisk walking programme.
In the present study, we compared the changes in glycaemic
control and cardiovascular risk profile following the prescrip-
tion of 12 months of either supervised group-based brisk-
walking or of a more individualised medical fitness
programme in a large population of type 2 diabetes patients
(n=92) in a primary healthcare setting. We report our results
for changes in HbA1c values as a primary outcome para-
meter, with blood pressure, plasma lipid levels, insulin
sensitivity by homeostasis model assessment (HOMA),
body composition, physical fitness, programme adherence
and health-related quality of life as secondary outcome
parameters. Given the greater improvements in glycaemic
control following combined endurance and resistance type
exercise training as opposed to each separately [3, 23], we
hypothesised that a medical fitness programme would




From June till December 2005, 493 patients with type 2 dia-
betes were preselected from a population of 12,197 patients
attending a primary healthcare centre that offers structured
and guideline-based [24] diabetes care programmes. After
5 months of active recruitment by two nurse practitioners
and four general practitioners, a total of 76 (=15.4%)
patients were willing to participate in supervised exercise
sessions three times a week for a period of at least 1 year.
The type 2 diabetes patients selected had been diagnosed
more than 3 months prior to screening according to the WHO
criteria [25]. Exclusion criteria were: presence of (silent)
cardiac or peripheral vascular disease, orthopaedic limita-
tions and/or diabetic foot ulceration. To increase sample size,
the exercise intervention programme was subsequently
advertised in local newspapers, which yielded another 26
potential study candidates. In total, 99 type 2 diabetes
patients agreed to participate in either brisk walking or
medical fitness programmes. Potential study candidates
performed a graded exercise test on a cycle ergometer
(Medifit; Medifit Systems, Maarn, the Netherlands) using a
ramp protocol [26]. Cardiac function was monitored using a
12-lead electrocardiogram and blood pressure was measured
to detect malignant hypertension. Of the 99 selected patients,
three did not show up and four were excluded because of an
abnormal stress-ECG. The remaining 92 volunteers were
randomly allocated to either brisk walking (n=49) or medical
fitness (n=43) programmes, by subsequently drawing a se-
quentially numbered opaque, sealed envelope (Fig. 1).
Laboratory personnel and the physician in charge of the
graded exercise tests and randomisation procedure were
blinded to the selection outcome of each participant. Drug
prescriptions of each patient were recorded through an
electronic database system operated through a network of
local pharmacies. As part of the diabetes protocol in the
healthcare centre, all type 2 diabetes patients consulted a
dietitian and/or diabetes nurse educator annually for dietary
guidance. Baseline participant characteristics are provided in
Table 1. The nature and the risks of the exercise intervention
were explained to all participants before written informed
consent was obtained. This study was approved by the local
Medical Ethical Committee of the Máxima Medical Centre,
Veldhoven, the Netherlands. Since the study protocol was
planned before 2005, official pre-trial registration at inter-
national trial registers was not performed.
Exercise intervention
Overview Two different exercise intervention programmes
were implemented over a 12-month period, during which
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three brisk walking or medical fitness sessions were per-
formed each week. The exercise load was progressive in
nature and had components of resistance and endurance type
exercise according to the American Diabetes Association/
American College of Sports Medicine guidelines [27].
Brisk walking programme The weekly volume of brisk
walking consisted of three 60 min exercise sessions. During
the first 3 months participants were supervised by certified
exercise trainers and a physical therapist. Group size varied
between 15 and 25 patients. After 3 months, certified trainers
guided and supervised the training sessions, while the physical
therapist was visited on a consultation basis. The endurance
type exercise consisted of brisk walking (5–6 km/h), with a
focus on interval type endurance exercise training. During the
intervention period the intensity was gradually increased and
averaged 75±5% of maximum heart frequency, as determined
during the maximal cycle ergometer test. The resistance type
exercise training consisted of resistance and floor exercises
using individual body weight and/or elastic bands (The
Hygenic Corporation, Akron, OH, USA). Further details on
the brisk walking programme are provided in Electronic
supplementary material (ESM) Table 1.
Medical fitness programme The medical fitness programme
consisted of three exercise sessions per week. Endurance type
exercise consisted of interval type exercise on a home trainer,
elliptical trainer or rowing ergometer with an average
intensity of 73±2% of maximum heart frequency. All training
sessions were tailored to individual performance capacity.
Resistance type exercise consisted of a selection of eight
different exercises targeting upper and lower body muscle
groups. Over a period of 6 months the training volume of the
medical fitness programme was progressively increased from
Assessed for eligibility 
(n=533) 
Entered screening  
(stress-ECG)  
Randomly allocated  
(n=92) 
Excluded (n=434) 
 Diabetes <3 months: 10
 Musculoskeletal restrictions: 77 
 Other medical conditions: 68 
 Not interested/other reason: 279 
Excluded (n=7) 
 Cardiac condition: 4 
 Not interested: 3 
Allocated to brisk walking (n=49) 
 Completed fewer than ten sessions: 9 
  Musculoskeletal problem aggrav- 
   ated by exercise: 5 
  Dissatisfied with programme: 1 
  Personal/time commitments: 3 
Allocated to medical fitness (n=43) 
 Completed fewer than ten sessions: 6 
  Musculoskeletal problem aggrav- 
   ated by exercise: 3 
  Other medical condition: 1 
Personal/time commitments: 2
Dropped out (n=22) 
 Musculoskeletal problem: 10 
 Personal/time commitments: 4 
 Other medical conditions: 4 
 Unknown/not reported: 4 
Dropped out (n=18) 
 Musculoskeletal problem: 9 
 Personal/time commitments: 4 
 Other medical conditions: 4 
 Unknown/not reported: 1 
Analysed (n=49) 
 Excluded from analysis: 0
 Missing data for HbA1c 
  At 3 months: 1 
  At 6 months: 6 
  At 9 months: 5  
  At 12 months: 11 
Analysed (n=43) 
 Excluded from analysis: 0 
 Missing data for HbA1c 
  At 3 months: 8 
  At 6 months: 9 
  At 9 months: 14  
  At 12 months: 11 
Fig. 1 Study flow diagram
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three times 30 min per week (90 min/week) towards a total of
180 to 225 min per week. Further details on the medical
fitness programme are provided in ESM Table 1.
Energy expenditure and monitoring blood glucose Based
on average heart rate and indirect calorimetry measurements
performed during either briskwalking [28] or circuit resistance
training in elderly [29] participants, energy expenditure in
both exercise interventions was estimated to range between
0.23 and 0.33 kJ kg−1 min−1. Given the participants’ body-
weights, the exercise interventions should be regarded as
moderate intensity. Participants were provided with blood
glucose monitor systems and test strips (A. Menarini
Diagnostics, Valkenswaard, the Netherlands) and during the
first month of brisk walking or medical fitness were advised
to assess capillary blood glucose levels ∼30 min before and
after exercise. Patients were instructed to report recurrent
hypoglycaemic events to their diabetes nurse educator or
general practitioner. For logistic reasons no systematic
enquiries on mild hypoglycaemic events were performed.
Financial cost of the intervention programmes Direct yearly
costs for the individualised medical fitness programme were
Euro 853 per participant and consisted of an ECG-stress test,
supervision and consultations by a physical therapist, and the use
of fitness centre facilities. The direct costs of the group-based
brisk walking programme averaged Euro 396 per participant.
Costs consisted of an ECG-stress test, supervision and consul-
tation by a physical therapist, and a brisk walking membership
fee. Other healthcare-related costs were not assessed.
Outcome variables
Resting heart rate and blood pressure Resting heart rate
and blood pressure were determined in a supine position
before and at 6 and 12 months after initiating the
exercise programme. Heart rate was stored and averaged
through a heart rate monitoring system (CO2ntrol;
Tildesign, Zeewolde, the Netherlands). Average systolic
and diastolic blood pressure were determined (HEM-
907; Omron Healthcare, Hoofddorp, the Netherlands)
from five successive measurements.
Physical fitness Before and at 12 months after the start of the
exercise programme, peak oxygen uptake capacity (VO

2peak )
was estimated based on maximum workload capacity (Wmax)
Table 1 Participants’ baseline
characteristics





on Wmax during cycling
ergometry and the equation
according to Storer et al. [30].





based on the equation by
Fairbarn et al. [31].
ACEI, ACE inhibitor; ARB,
angiotensin receptor blocker;
BW, body weight
Characteristic Total (n=92) Brisk walking (n=49) Medical fitness (n=43)
Age (years) 60±9 61±9 59±9
Men/women (n) 47/45 27/22 20/23
Duration of diabetes (years) 5±5 5±4 5±5
BW (kg) 94.3±18.4 94.1±18.1 94.5±19.0
BMI (kg/m2) 32.3±5.5 32.1±5.2 32.5±6.0
Wmax (W) 156±47 155±49 157±45
Estimated VO

2peak (l/min) 2.1±0.6 2.1±0.6 2.1±0.6
%Pred. VO

2peak 82±11 82±10 83±11
Participants treated with:
Diet only (n) 11 5 6
Hypoglycaemic agents (n)
Total 81 44 37
Metformin 43 24 19
Sulfonylurea 25 13 12
Thiazolidinedione 10 4 6
Insulin 13 6 7
Antihypertensive agents (n)
Total 59 32 27
ACEI/ARB 39 20 19
Beta-blocker 17 7 10
Diuretic 19 10 9
Calcium-channel blocker 9 5 4
Other 3 1 2
Lipid-lowering agents (n)
Total 54 30 24
Statin 53 29 24
Fibrate 1 1 0
Other 0 0 0
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during cycling ergometry according to Storer et al. [30].
Relative age-, height- and sex-adjusted cardio-respiratory
fitness (%Pred. VO

2peak ) was defined as the ratio between
estimated VO

2peak and predicted VO

2peak as determined in a
healthy non-diabetic population [31].
Blood analyses Two weeks before and at 3, 6, 9 and
12 months after initiating the exercise programme, fasting
blood samples were collected. Blood samples collected before
and after 3 and 9 months of intervention were analysed for
HbA1c and basal glucose concentration. On the evening prior
to blood sampling, participants remained fasted from
00:00 hours onwards. They arrived at the laboratory at
08:00 hours, having travelled by car or public transport. After
5 to 10 min of rest, a venous blood sample was collected from
an antecubital vein. Blood samples were collected in tubes
containing a glycolytic inhibitor (sodium fluoride) and an
anticoagulant (potassium oxalate), immediately centrifuged
for 5 min at 1,000×g and 4°C, after which aliquots of plasma
were immediately frozen in liquid nitrogen and stored at
−80°C until analyses. Plasma glucose (dehydrogenase
assay), triacylglycerol (lipase/peroxidase assay) concentra-
tions, and total serum cholesterol (peroxidase/cholesterol-
esterase assay), HDL-cholesterol (peroxidase esterase assay)
and LDL-cholesterol (according to the Friedewald formula if
triacylglycerol was <4.5 mmol/l, otherwise through direct
peroxidase esterase assay) were analysed (Synchron LX20;
Beckman Coulter, Fullerton, CA, USA). Plasma insulin was
determined in duplicate by electrochemiluminescence-
immunoassay (Elecsys 2010; Roche, Mannheim, Germany).
Because of cross-sensitivity in the latter assay, exogenous
insulin users were excluded from this analysis. HOMA
insulin resistance index [32] was assessed to monitor
changes in insulin sensitivity [33]. To determine HbA1c,
3 ml blood samples were collected and analysed by high-
performance liquid chromatography (HA8160 Menarini;
A. Menarini Diagnostics, Florence, Italy).
Quality-of-life assessment
Health-related quality-of-life was measured with the RAND
36-ItemHealth Survey 1.0 [34, 35] before and after 12 months
of exercise intervention.
Statistical analyses
We calculated that 74 persons (37 per group) were needed to
have 80% power to detect a moderate 0.65 SD difference in
HbA1c as primary endpoint parameter between brisk walking
and medical fitness programme, with an α of 0.05. Sample
size was exceeded to allow for an estimated withdrawal of
∼15%. Data were analysed according to the intention-to-treat
(ITT) principle. To minimise type I errors and loss of power
[36], endpoint analyses according to the last observation
carried forward principle were performed for missing values
at 12 months follow-up. To assess whether physiological
differences existed between the long-term application of
brisk walking and medical fitness programme, post hoc
analyses were performed for individuals actively participat-
ing for 10 months or more. Data are expressed as means±
SD. ANOVA repeated measures was used to determine
differences between baseline and status after 12 months of
exercise intervention. Unpaired Student’s t, χ2 and Mann–
Whitney U tests were used to test whether long-term changes
observed in brisk walking differed from those seen in the
medical fitness programme. Significance was set at the
0.05 level of confidence. Pearson’s correlation calculation
was used to test for linear relationships between long-term
changes in dependent variables. All statistical calculations
were performed using SPSS 10.1 (SPSS, Chicago, IL,
USA).
Results
Characteristics of the study population
Following randomisation there were no significant differ-
ences in baseline characteristics, sex and anthropometry
between brisk walking and medical fitness programme
groups (Table 1).
Programme adherence, follow-up and adverse events
After 6 months of intervention, 22 (45%) brisk walking
participants and 13 (30%) medical fitness programme partic-
ipants (p=0.15) were no longer participating (ESM Table 2).
After 12 months, 18 (37%) brisk walking and 19 (44%)
medical fitness participants respectively were still actively
participating with mean adherence levels of 75±16% and
68±13% (p>0.05) for the 156 available exercise sessions
(ESM Table 2). Besides motivational reasons (25%),
orthopaedic-related co-morbidities, such as overuse injuries
and/or subclinical osteoarthritis of the lower extremities,
formed the main reason for dropout in 48 and 50% of the
brisk walking and medical fitness programme participants,
respectively (Fig. 1, Table 2). The distribution of missing
data points was similar and not statistically different between
groups (p>0.05).
Glycaemic control
According to ITT analyses, changes in HbA1c values
following the prescription of brisk walking or medical
fitness intervention were identical (95% CI −0.42, 0.43;
p=0.99) (Table 3). A total of 12 patients (brisk walking,
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n=5; medical fitness, n=7) had been prescribed higher
doses of blood glucose-lowering medication throughout
the follow-up period. When these participants were excluded
from our ITT analysis, HbA1c increased by 0.05% (95%
CI −0.41, 0.51; p=0.82) in brisk walking as compared with
medical fitness programme. Post hoc analyses of long-term
active participants (≥10 months with mean adherence level
of 62±17 and 70±18% in brisk walking and medical fitness
groups, respectively) showed that, independently of changes
in prescribed blood glucose-lowering drugs, HbA1c in the
brisk walking group increased by 0.53% (95% CI 0.07,
1.00; p=0.025) as compared with the medical fitness group
(ESM Table 3).
Resting heart rate and blood pressure
Following the 12 month exercise intervention, resting heart
rate in the brisk walking group was reduced by 0.9 beats per
min (bpm) (CI −7.1, 5.3; p=0.68) as compared with medical
fitness group. No significant differences in blood pressure
response were observed between the two interventions
(Table 3). After excluding participants who were prescribed
higher doses of antihypertensive drugs (brisk walking, n=5;
medical fitness, n=7), mean arterial blood pressure
decreased by 0.9 mmHg (95% CI −5.6, 3.9; p=0.94) in
the brisk walking as compared with medical fitness group.
A post hoc analysis of 46 long-term active participants
showed a non-significant difference in mean arterial blood
pressure of −3.5 mmHg (95% CI −9.2, 2.2; p=0.22) in the
brisk walking compared with the medical fitness programme
(ESM Table 3).
Blood lipid profile
After 12 months, the overall fasting lipid profile did not differ
between the two groups (Table 3). When participants (brisk
walking, n=9, medical fitness, n=7) who were prescribed
more blood lipid-lowering agents were excluded, HDL-
cholesterol had changed by −0.05 mmol/l (95% CI −0.12,
0.02; p=0.17) in the medical fitness compared with the brisk
walking group.
Body composition and workload capacity
Body composition (BMI) did not change (Table 3). Workload
capacity as measured during cycle ergometry averaged 155±
49 and 157±45 W in the brisk walking and medical fitness
programme groups, respectively, changing by −4.3 W (95%
CI −9.1, 0.5; p=0.078) in the former and by −2.5 W (95%
CI−10, 5.6; p=0.53) in the latter, with a non-significant
difference of −1.8 W (95% CI −10.5, 6.9; p=0.68) in brisk
walking compared with medical fitness programme partic-
ipants. Maximum heart rates recorded during ergometry
averaged 146±22 and 152±19 bpm at baseline, and 152±21
and 149±22 bpm following 12 months of exercise interven-
tion in the brisk walking and medical fitness groups,
respectively (p>0.05). In our long-term active brisk walking
participants, Wmax changed by −6.3 W (95% CI −16.5, 3.9;
p=0.22) as compared with their medical fitness programme
counterparts. No significant correlations were found between
changes in HbA1c values and changes in workload capacity
(ΔWmax, Pearson’s R=0.02, p=0.93, n=38) or body weight
(Pearson’s R=0.18, p=0.225, n=45).
Table 2 Adverse medical events
Events Brisk walking (n=49) Medical fitness (n=43)
Adverse events related to exercise intervention 15 12
Shoulder pain/chronic tendinopathy of rotator cuff 0 1
(Aggravation of) low back pain 2 2
Aggravation of pre-existing osteoarthritis in hip or knee joint 6 4
Shin splints/lower leg pain 1 0
Chronic tendinopathy of Achilles tendon/plantar fascia 3 1
Other/generalised musculoskeletal discomfort 3 3
Adverse events not related to exercise intervention 4 6
Medical event requiring hospitalisationa 3 3
Other serious medical eventb 1 3
Participants with adverse event resulting in withdrawal 19 17
Data are number of participating diabetes patients that experienced an adverse event throughout the 12 months follow-up period
a Hospitalisations were related to: arthroscopic knee surgery (brisk walking, n=1), elective surgery for chronic abdominal aortic aneurysm (brisk
walking, n=1), elective cataract surgery (brisk walking, n=1), elective knee joint replacement (medical fitness, n=1), bacterial pneumonia
(medical fitness, n=1), elective varicose veins surgery (medical fitness, n=1, did not result in withdrawal from study).
b Other serious medical events requiring medical attention were: otitis externa (brisk walking) n=1, atrial fibrillation (medical fitness) n=1, newly
diagnosed myocardial ischaemia (medical fitness) n=1, and newly diagnosed carcinoma of the mammary gland (medical fitness) n=1
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Table 3 Changes in diabetes outcome (ITT analysis)
Variable Change from baseline to 12 months
Mean±SD n Mean±SD n Difference 95% CI p Value
HbA1c (%)
Total 7.13±1.36 92 6.99±1.26 71
Brisk walking group 7.18±1.42 49 7.08±1.37 38
Medical fitness group 7.08±1.29 43 6.89±1.13 33
Intragroup comparisons
Intragroup comparison total −0.14 −0.39, 0.03 0.153
Intragroup comparison brisk walking −0.11 −0.51, 0.15 0.464
Intragroup comparison medical fitness −0.18 −0.45, 0.09 0.176
Brisk walking vs medical fitness 0.00 −0.42, 0.43 0.985
BMI (kg/m2)
Total 32.3±5.5 92 31.8±5.4 89
Brisk walking group 32.1±5.2 49 31.9±5.0 48
Medical fitness group 32.5±6.0 43 31.7±5.9 41
Intragroup comparisons
Intragroup comparison total −0.5 −1.1, 0.1 0.108
Intragroup comparison brisk walking −0.2 −0.6, 0.3 0.471
Intragroup comparison medical fitness −0.8 −2.0, 0.3 0.152
Brisk walking vs medical fitness 0.7 −0.5, 1.9 0.237
Fasting plasma glucose (mmol/l)
Total 8.44±2.81 92 8.21±2.37 71
Brisk walking group 8.64±2.83 49 8.33±2.64 38
Medical fitness group 8.21±2.80 43 8.06±2.05 33
Intragroup comparisons
Intragroup comparison total −0.23 −0.72, 0.25 0.345
Intragroup comparison brisk walking −0.31 −0.96, 0.34 0.344
Intragroup comparison medical fitness −0.15 −0.91, 0.61 0.699
Brisk walking vs. medical fitness −0.16 −1.14, 0.82 0.744
HOMAa
Total 5.55±3.68 68 5.60±3.38 54
Brisk walking group 5.86±3.56 37 5.75±3.20 30
Medical fitness group 5.19±3.58 31 5.43±3.64 24
Intragroup comparisons
Intragroup comparison total 0.05 −0.50, 0.62 0.833
Intragroup comparison brisk walking −0.12 −1.11, 0.85 0.794
Intragroup comparison medical fitness 0.24 −0.19, 0.74 0.241
Brisk walking vs medical fitness −0.40 −1.52, 0.72 0.479
Resting heart rate (bpm)
Total 73.4±11.8 91 69.6±13.9 77
Brisk walking group 72.6±11.8 48 68.3±15.0 41
Medical fitness group 74.4±11.8 43 71.0±12.4 36
Intragroup comparisons
Intragroup comparison total −3.9 −5.9, −1.8 0.000
Intragroup comparison brisk walking −4.3 −7.4, −1.1 0.009
Intragroup comparison medical fitness −3.4 −5.9, −0.9 0.010
Brisk walking vs medical fitness −0.9 −4.9, 3.2 0.678
Systolic blood pressure (mmHg)
Total 148.5±18.1 91 137.5±15.5 77
Brisk walking group 150.3±18.9 48 138.9±16.3 41
Medical fitness group 146.3±17.1 43 135.9±14.6 36
Intragroup comparisons
Intragroup comparison total −10.9 −14.0, −7.8 0.000
Intragroup comparison brisk walking −11.4 −15.9, −6.8 0.000
Intragroup comparison medical fitness −10.4 −14.7, 6.2 0.000
Brisk walking vs medical fitness −0.9 −7.1, 5.3) 0.768
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Table 3 (continued)
Variable Change from baseline to 12 months
Mean±SD n Mean±SD n Difference 95% CI p Value
Diastolic blood pressure (mmHg)
Total 81.9±10.6 91 76.6±8.3 77
Brisk walking group 81.3±10.8 48 75.9±8.8 41
Medical fitness group 82.6±10.4 43 77.4±7.7 36
Intragroup comparisons
Intragroup comparison total −5.3 −7.1, −3.6 0.000
Intragroup comparison brisk walking −5.4 −7.8, 2.9 0.000
Intragroup comparison medical fitness −5.2 −7.8, −2.7 0.000
Brisk walking vs medical fitness −0.1 −3.6, 3.4 0.949
Total cholesterol level (mmol/l)
Total 4.70±0.86 88 4.53±0.94 65
Brisk walking group 4.83±0.89 47 4.61±0.92 35
Medical fitness group 4.54±0.12 41 4.44±0.96 30
Intragroup comparisons
Intragroup comparison total −0.16 −0.32, −0.01 0.035
Intragroup comparison brisk walking −0.22 −0.45, 0.01 0.064
Intragroup comparison medical fitness −0.10 −0.30, 0.10 0.307
Brisk walking vs medical fitness −0.12 −0.42, 0.19 0.453
LDL-cholesterol level (mmol/l)
Total 2.83±0.76 88 2.70±0.79 64
Brisk walking group 2.90±0.82 47 2.72±0.85 35
Medical fitness group 2.74±0.69 41 2.68±0.72 29
Intragroup comparisons
Intragroup comparison total −0.12 −0.26, 0.01 0.070
Intragroup comparison brisk walking −0.18 −0.38, 0.02 0.080
Intragroup comparison medical fitness −0.06 –0.25, 0.12 0.493
Brisk walking vs medical fitness −0.11 −0.38, 0.16 0.401
HDL-cholesterol level (mmol/l)
Total 1.09±0.28 88 1.10±0.29 65
Brisk walking group 1.10±0.23 47 1.09±0.26 35
Medical fitness group 1.07±0.33 41 1.11±0.32 30
Intragroup comparisons
Intragroup comparison total −0.01 –0.02, 0.04 0.570
Intragroup comparison brisk walking −0.01 −0.06, 0.04 0.629
Intragroup comparison medical fitness 0.03 −0.01, 0.08 0.129
Brisk walking vs medical fitness −0.05 −0.12, 0.02 0.172
Triacylglycerol level (mmol/l)
Total 1.88±0.99 88 1.79±0.91 64
Brisk walking group 2.00±1.08 47 1.94±0.98 35
Medical fitness group 1.74±0.88 41 1.61±0.79 29
Intragroup comparisons
Intragroup comparison total −0.09 −0.25, 0.06 0.239
Intragroup comparison brisk walking −0.06 −0.33, 0.17 0.646
Intragroup comparison medical fitness −0.13 −0.27, 0.06 0.120
Brisk walking vs medical fitness −0.02 −0.29, 0.33 0.892
RAND-36 (score 0–100 scale)
Total 71±15 89 70±15 58
Brisk walking group 69±15 46 68±15 31
Medical fitness group 73±15 43 71±14 27
Intragroup comparisons
Intragroup comparison total −0.6 −2.4, 1.2 0.503
Intragroup comparison brisk walking 0.1 –2.7, 2.8 0.969
Intragroup comparison medical fitness −1.4 −3.8, 1.1 0.261
Brisk walking vs medical fitness 1.4 −2.2, 5.0 0.438
Data are means±SD. n=number of valid measurements. a For HOMA calculations exogenous insulin users (n=13) were excluded
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Quality of life assessment
A total of 89 and 58 participants completed the RAND-36
questionnaire at baseline and after 12 months of interven-
tion, respectively. Reliability and internal consistency was
excellent with Cronbach’s alpha of 0.93 and 0.91 respec-
tively. No significant difference in changes of total RAND-
36 scores were observed between the two intervention
groups (p>0.05; Table 3).
Discussion
It has been firmly established that physical activity counsel-
ling [37] and participation in structured exercise intervention
programmes [15, 19] improves glycaemic control. However,
long-term intervention studies on the clinical benefits of
different types of exercise intervention programmes in type
2 diabetes patients are lacking. In the present study, we
compared the clinical benefits of 12 months of a group-
based brisk walking programme versus a more individu-
alised medical fitness programme. ITT analysis showed that
the prescription of a group-based, brisk walking programme
is not necessarily inferior to a more individualised medical
fitness programme with regard to glycaemic control and
markers for cardiovascular risk profile (Table 3). Our data
therefore imply that most patients with type 2 diabetes will
achieve more or less equal long-term therapeutic benefits
from a low-impact brisk walking programme as opposed to
a more individualised medical fitness programme. Never-
theless, long-term programme adherence and the possibility
of dropout should be taken into consideration when
prescribing either type of exercise intervention for a patient
with type 2 diabetes. Independently of the provided level of
guidance and infrastructure, 60% of the patients dropped out
of the exercise programme during the 12 month intervention
period, with no differences in adherence and dropout
patterns between brisk walking and medical fitness
programme. Although motivational factors explained 25%
of the dropout in both exercise programmes, almost 50% of
the dropout was attributed to orthopaedic-related co-
morbidities and overuse injuries of the lower extremities.
The latter was not anticipated, since clinically relevant
orthopaedic limitations, such as a history of osteoarthritis of
the hip or knee joint, were defined as exclusion criteria for
participation in either exercise intervention programme.
Apparently, subclinical joint disease and/or degeneration of
myotendineous structures become apparent when physical
activity levels are increased. Stiffening of connective tissue
due to non-enzymatic advanced glycation end-product
formation [38], as well as decreased collagen turnover due
to ageing and chronic disuse [39], could be responsible for
the impaired response to increased musculoskeletal loading
in these patients. Although more fundamental clinical
research is warranted, the high incidence of overuse injuries
in the present study adds to the results described in another
study [23], suggesting that in unselected, non-study pop-
ulations dropout will be even greater. Therefore, it might be
advisable to implement a more gradual and less intense
exercise regimen to allow myotendineous structures to adapt
to increased loading. Moreover, before prescribing thera-
peutic exercise, diabetes healthcare workers should carefully
consider obesity- and diabetes-related musculoskeletal
deconditioning [40–42]. Such programmes should probably
focus even more on resistance type exercise activities [43,
44] to bring patients to a level at which they are able to
participate and adhere to more generic diabetes intervention
programmes. It has also been suggested that psychological
strategies such as motivational interviewing [45] or booster
sessions [21, 46] might help to further improve programme
adherence. Nevertheless, more long-term, tailored exercise
intervention studies are warranted to further define the most
effective and feasible exercise interventional strategy.
The absence of a significant decline in blood HbA1c levels
in brisk walking participants does not imply that the
prescription of low-impact, endurance type exercise has no
therapeutic value [3, 7, 27, 47–49]. In fact, we observed
significant improvements in blood pressure control following
either type of exercise intervention (Table 3). Although
reliable assessment of actual drug use was not possible in the
present study, the improvements in blood pressure occurred
independently of changes in the prescription of antihyperten-
sive medication. However, the lack of a non-exercise control
group in the present study makes it impossible to speculate
on cause and effect, since changes in blood pressure from
baseline might also, or at least partly, be explained by the
Hawthorne effect, for example, or by familiarisation with
blood pressure measurement protocols. Nevertheless, our
data suggest that the structured application of group-based
brisk walking and supervised medical fitness programmes
tends to have a similar impact on cardiovascular risk profile.
In conclusion, the prescription of group-based brisk
walking represents an equally effective interventional strat-
egy to modulate glycaemic control and cardiovascular risk
profile in type 2 diabetes patients compared with a more
individualised medical fitness programme. General decondi-
tioning, musculoskeletal overuse injuries and lack of moti-
vation limit the benefits of long-term exercise intervention as
an add-on to a comprehensive diabetes care programme.
Future diabetes exercise intervention programmes in primary
healthcare settings should consider diabetes-related co-
morbidities and patient motivation as important factors,
which determine both long-term programme adherence and
the associated clinical benefits.
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